Cover Image
市場調查報告書

口唇皰疹:全球臨床實驗趨勢

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 233627
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
口唇皰疹:全球臨床實驗趨勢 Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017
出版日期: 2017年09月15日 內容資訊: 英文 69 Pages
簡介

本報告提供口唇皰疹相關臨床研究的最新趨勢的相關分析,彙整各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

本報告概要

調查範圍

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上口唇皰疹的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上口唇皰疹的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

口唇皰疹治療藥臨床實驗主要的參與企業

有潛力的藥劑

口唇皰疹臨床實驗相關最新趨勢

臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4580CTIDB

GlobalData's clinical trial report, "Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2017" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials 28
  • Prominent Drugs 30
  • Latest Clinical Trials News on Herpes Labialis (Oral Herpes) 31
  • Aug 23, 2017: AiCuris Announces Final Patient Treated in Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes 31
  • Clinical Trial Profile Snapshots 32

Appendix 67

  • Abbreviations 67
  • Definitions 67
  • Research Methodology 68
  • Secondary Research 68
  • About GlobalData 69
  • Contact Us 69
  • Source 69

List of Tables

List of Tables

  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
  • Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
  • Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures

List of Figures

  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
  • Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
  • Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
  • GlobalData Methodology 68
Back to Top